• Home
  •  / Globus Medical

Globus Medical

OverviewSuggest Edit

Globus Medical, Inc. is a medical device company focused on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company's products are classified into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products are used in cervical, thoracolumbar, sacral, and interbody, corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions.
TypePublic
Founded2003
HQEagleville, PA, USMap
Websiteglobusmedical.com
Employee Ratings2.9More
Overall CultureB+More
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Dec 2019)2,000(+12%)
Revenue (FY, 2019)$785.4 M(+11%)
Share Price (Jan 2021)$65.4 (+3%)
Cybersecurity ratingCMore

Key People/Management at Globus Medical

David C. Paul

David C. Paul

Executive Chairman
Daniel T. Scavilla

Daniel T. Scavilla

Executive Vice President and Chief Commercial Officer
Kelly G. Huller

Kelly G. Huller

Senior Vice President, General Counsel and Corporate Secretary
A. Brett Murphy

A. Brett Murphy

Group President Commercial Operations
Show more

Globus Medical Office Locations

Globus Medical has an office in Eagleville
Eagleville, PA, US (HQ)
2560 General Armistead Ave
Show all (1)

Globus Medical Financials and Metrics

Globus Medical Revenue

Embed Graph
View revenue for all periods
Globus Medical's revenue was reported to be $785.37 m in FY, 2019
USD

Revenue (Q3, 2020)

216.1m

Gross profit (Q3, 2020)

159.0m

Gross profit margin (Q3, 2020), %

73.6%

Net income (Q3, 2020)

44.2m

EBIT (Q3, 2020)

50.0m

Market capitalization (20-Jan-2021)

6.4b

Closing stock price (20-Jan-2021)

65.4

Cash (30-Sept-2020)

250.6m
Globus Medical's current market capitalization is $6.4 b.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

386.0m434.5m474.4m544.8m564.0m636.0m713.0m785.4m

Revenue growth, %

9%15%4%

Cost of goods sold

75.2m100.3m110.9m132.8m134.7m150.5m159.4m180.0m

Gross profit

310.8m334.1m363.5m412.0m429.3m485.5m553.6m605.4m
Quarterly
USDQ2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q2, 2020Q3, 2020

Revenue

96.0m94.8m105.0m107.0m107.2m114.2m113.6m117.8m131.6m133.6m137.0m139.3m137.5m135.7m155.8m152.4m151.7m174.4m173.4m169.2m182.9m194.5m196.2m148.9m216.1m

Cost of goods sold

18.4m18.9m23.5m23.5m25.3m25.3m26.6m27.7m32.1m32.6m33.1m31.6m32.9m31.5m35.6m37.2m36.8m38.0m37.6m37.8m41.8m44.0m45.4m50.6m57.1m

Gross profit

77.6m75.9m81.5m83.5m81.9m88.9m87.0m90.1m99.5m101.0m103.9m107.6m104.6m104.2m120.2m115.2m114.9m136.4m135.7m131.4m141.1m150.5m150.8m98.3m159.0m

Gross profit Margin, %

81%80%78%78%76%78%77%76%76%76%76%77%76%77%77%76%76%78%78%78%77%77%77%66%74%
show all
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

212.4m90.0m82.3m60.2m132.6m118.8m139.6m195.5m

Accounts Receivable

53.5m62.4m75.4m77.7m116.7m137.1m154.3m

Prepaid Expenses

3.0m5.1m5.7m7.4m11.2m15.4m17.2m

Inventories

62.3m70.4m90.9m105.3m112.7m108.4m131.3m196.3m
Quarterly
USDQ2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q2, 2020Q3, 2020

Cash

165.6m195.2m131.5m92.3m101.9m104.6m136.5m169.4m75.0m41.6m50.5m81.3m95.3m90.2m182.4m149.7m154.9m119.8m119.9m145.3m130.0m117.8m166.1m165.6m250.6m

Accounts Receivable

49.5m51.9m59.4m57.5m55.3m63.2m65.1m62.6m73.2m73.0m77.6m75.5m74.7m86.7m94.2m95.5m94.5m122.6m118.6m118.8m139.6m144.7m141.5m132.1m143.3m

Prepaid Expenses

4.0m3.2m4.4m5.5m6.1m4.7m5.4m6.2m5.1m6.8m7.1m6.0m5.4m11.6m7.0m5.9m9.4m13.0m16.9m14.0m12.9m13.5m14.8m19.6m19.1m

Inventories

53.1m57.0m66.9m71.4m71.2m72.5m76.4m77.4m98.9m101.0m105.7m105.1m104.4m115.6m113.0m111.1m111.5m107.6m114.8m124.4m143.4m173.0m187.1m224.5m231.9m
show all
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

73.8m68.6m92.5m112.8m104.3m107.3m156.5m155.2m

Depreciation and Amortization

18.1m19.4m21.8m24.1m38.8m42.1m41.6m52.7m

Inventories

(20.5m)(16.7m)(18.0m)(19.3m)(10.5m)(5.3m)(31.4m)(50.0m)

Accounts Payable

3.0m1.8m4.6m(3.8m)(23.0k)9.8m(3.0m)773.0k
Quarterly
USDQ2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q2, 2020Q3, 2020

Net Income

36.6m53.1m19.9m27.3m47.6m21.1m41.8m64.8m24.6m48.7m75.2m28.0m53.8m80.0m28.7m57.4m83.0m39.5m84.5m119.7m33.2m71.4m109.7m5.1m49.3m

Depreciation and Amortization

8.9m13.5m4.6m9.4m14.2m5.3m10.7m16.1m5.7m11.6m17.7m6.7m13.7m21.5m12.2m22.9m33.8m9.5m19.2m29.7m12.3m25.1m38.7m29.7m46.0m

Inventories

(9.3m)(14.6m)(7.0m)(13.0m)(15.7m)(4.0m)(9.5m)(12.5m)(7.4m)(11.7m)(17.0m)(2.3m)(3.8m)(6.6m)(2.1m)(4.7m)(7.0m)(1.2m)(11.1m)(23.0m)(13.8m)(28.1m)(40.9m)(34.4m)(47.3m)

Accounts Payable

1.8m34.0k(320.0k)243.0k1.0m(1.1m)(821.0k)(2.3m)835.0k(66.0k)(2.8m)(1.2m)(1.7m)(3.4m)(172.0k)(1.7m)(344.0k)728.0k(5.8m)(4.9m)2.8m(901.0k)(158.0k)3.0m5.4m
show all
USDQ2, 2012

Financial Leverage

1.1 x
Show all financial metrics

Globus Medical Cybersecurity Score

Cybersecurity ratingPremium dataset

C

73/100

Learn more about our premium products
SecurityScorecard logo

Globus Medical Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

Learn more about our premium products
CSRHub logo

Globus Medical Online and Social Media Presence

Globus Medical's Trends

Embed Graph

Globus Medical Company Culture

  • Overall Culture

    B+

    77/100

  • CEO Rating

    B

    73/100

  • Compensation

    A

    84/100

Learn more on Comparably

Globus Medical News and Updates

January 11, 2021

Global Spinal Fusion Market Analysis and Forecast Model to 2030, Featuring Key Players Medtronic plc, NuVasive Inc, DePuy Synthes Inc, Globus Medical Inc and More

Dublin, Jan. 11, 2021 (GLOBE NEWSWIRE) -- The "Spinal Fusion (Orthopedic Devices) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering. The model discusses in detail the impact of COVID-19 on Spinal Fusion market for the …
November 12, 2020

Globus Medical Announces First Surgeries with ExcelsiusGPS® Interbody Solutions

New ExcelsiusGPS® Interbody Solutions module expands system for planning and navigating the entire interbody fusion procedure New ExcelsiusGPS® Interbody Solutions module expands system for planning and navigating the entire interbody fusion procedure
August 07, 2020

Thinking about trading options or stock in Penn National Gaming, StoneCo Ltd, Facebook, Globus Medical, or Walt Disney?

NEW YORK, Aug. 7, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PENN, STNE, FB, GMED, and DIS. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...
May 22, 2020

Thinking about trading stocks or options in Globus Medical, Alaska Air Group, Lululemon Athletica, Palo Alto Networks, or Carnival Corp?

NEW YORK, May 22, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GMED, ALK, LULU, PANW, and CCL. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...
February 20, 2020

Globus Medical Reports Fourth Quarter and Full Year 2019 Results

AUDUBON, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2019.
August 01, 2019

Globus Medical Reports Second Quarter 2019 Results

AUDUBON, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2019.
Show more

Globus Medical Blogs

October 28, 2020

Globus Medical Reports Third Quarter 2020 Results

AUDUBON, Pa. , Oct. 28, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2020 . Worldwide net sales were $216 .1 million, an increase of 10.1% as compared to the third
August 05, 2020

Globus Medical Reports Second Quarter 2020 Results

AUDUBON, Pa. , Aug. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2020 . Worldwide sales were $148 .9 million, a decrease of 23.4% as reported Second quarter
July 21, 2020

Globus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call

Globus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call Content Import Tue, 07/21/2020 - 16:16 Globus Medical Schedules Second Quarter 2020 Earnings Release and Conference Call Jul 21, 2020 This release is a backfill from a News Wire …
June 15, 2020

Kaila Krum

Kaila Krum william.meady@… Mon, 06/15/2020 - 12:12 Kaila Krum SunTrust Robinson
May 07, 2020

Globus Medical Reports First Quarter 2020 Results

AUDUBON, Pa. , May 07, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2020 . Worldwide sales were $190 .6 million, an increase of 4.2% as reported First quarter net
March 11, 2020

Globus Medical Announces $200 Million Share Repurchase Program

Globus Medical Announces $200 Million Share Repurchase Program Content Import Wed, 03/11/2020 - 17:40 Globus Medical Announces $200 Million Share Repurchase Program Mar 11, 2020 This release is a backfill from a News Wire General AUDUBON, Pa., Marc…
Show more

 Globus Medical Frequently Asked Questions

  • When was Globus Medical founded?

    Globus Medical was founded in 2003.

  • Who are Globus Medical key executives?

    Globus Medical's key executives are David C. Paul, Daniel T. Scavilla and Kelly G. Huller.

  • How many employees does Globus Medical have?

    Globus Medical has 2,000 employees.

  • What is Globus Medical revenue?

    Latest Globus Medical annual revenue is $785.4 m.

  • What is Globus Medical revenue per employee?

    Latest Globus Medical revenue per employee is $392.7 k.

  • Who are Globus Medical competitors?

    Competitors of Globus Medical include Zimmer Biomet, Stryker and Medtronic.

  • Where is Globus Medical headquarters?

    Globus Medical headquarters is located at 2560 General Armistead Ave, Eagleville.

  • Where are Globus Medical offices?

    Globus Medical has an office in Eagleville.

  • How many offices does Globus Medical have?

    Globus Medical has 1 office.